Genetic Testing Market by Type (Predictive Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Application (Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.3. Porter’s five forces analysis

3.4. Top Player Positioning, 2017

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Increase in incidence of genetic disorders & cancer

3.5.1.2. Rise in awareness & acceptance of personalized medicines

3.5.1.3. Advancements in genetic testing techniques

3.5.2. Restraint

3.5.2.1. Standardization concerns of genetic testing-based diagnostics

3.5.2.2. Stringent regulatory requirements for product approvals

3.5.3. Opportunities

3.5.3.1. Untapped emerging markets in developing countries

3.6. Patent analysis (2015-2018)

3.6.1. Patent analysis, by year

3.6.2. Patent analysis for year 2017, by country

Chapter: 4: GENETIC TESTING MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Predictive and presymptomatic testing

4.2.1. Key trends and opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

4.3. Carrier testing

4.3.1. Key market trends and opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

4.4. Prenatal and newborn testing

4.4.1. Key market trends and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

4.5. Diagnostic testing

4.5.1. Key market trends and opportunities

4.5.2. Market size and forecast

4.5.3. Market analysis, by country

4.6. Pharmacogenomic testing

4.6.1. Key trends and opportunities

4.6.2. Market size and forecast

4.6.3. Market analysis, by country

4.7. Others

4.7.1. Key trends and opportunities

4.7.2. Market size and forecast

4.7.3. Market analysis, by country

Chapter: 5: GENETIC TESTING MARKET, BY TECHNOLOGY

5.1. Overview

5.1.1. Market size and forecast

5.2. Cytogenetic testing/chromosome analysis

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

5.3. Biochemical testing

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

5.4. Molecular testing

5.4.1. Market size and forecast, by type

5.4.2. DNA Sequencing

5.4.2.1. Market size and forecast, by region

5.4.3. Others

5.4.3.1. Market size and forecast, by region

5.4.4. Market size and forecast

5.4.5. Market analysis, by country

Chapter: 6: GENETIC TESTING MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Cancer diagnosis

6.2.1. Market size and forecast

6.2.2. Market analysis, by country

6.3. Genetic disease diagnosis

6.3.1. Market size and forecast

6.3.2. Market analysis, by country

6.4. Cardiovascular disease diagnosis

6.4.1. Market size and forecast

6.4.2. Market analysis, by country

6.5. Others

6.5.1. Market size and forecast

6.5.2. Market analysis, by country

Chapter: 7: GENETIC TESTING MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities

7.2.2. Market size and forecast, by test type

7.2.3. Market size and forecast, by technology

7.2.4. Market size and forecast, by application

7.2.5. Market size and forecast, by country

7.2.5.1. U.S. market size and forecast, by test type

7.2.5.2. U.S. market size and forecast, by technology

7.2.5.3. U.S. market size and forecast, by application

7.2.5.4. Canada market size and forecast, by test type

7.2.5.5. Canada market size and forecast, by technology

7.2.5.6. Canada market size and forecast, by application

7.2.5.7. Mexico market size and forecast, by test type

7.2.5.8. Mexico market size and forecast, by technology

7.2.5.9. Mexico market size and forecast, by application

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Market size and forecast, by test type

7.3.3. Market size and forecast, by technology

7.3.4. Market size and forecast, by application

7.3.5. Market size and forecast, by country

7.3.5.1. Germany market size and forecast, by test type

7.3.5.2. Germany market size and forecast, by technology

7.3.5.3. Germany market size and forecast, by application

7.3.5.4. France market size and forecast, by test type

7.3.5.5. France market size and forecast, by technology

7.3.5.6. France market size and forecast, by application

7.3.5.7. UK market size and forecast, by test type

7.3.5.8. UK market size and forecast, by technology

7.3.5.9. UK market size and forecast, by application

7.3.5.10. Italy market size and forecast, by test type

7.3.5.11. Italy market size and forecast, by technology

7.3.5.12. Italy market size and forecast, by application

7.3.5.13. Spain market size and forecast, by test type

7.3.5.14. Spain market size and forecast, by technology

7.3.5.15. Spain market size and forecast, by application

7.3.5.16. rest of Europe market size and forecast, by test type

7.3.5.17. rest of Europe market size and forecast, by technology

7.3.5.18. Rest of Europe market size and forecast, by application

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Market size and forecast, by test type

7.4.3. Market size and forecast, by technology

7.4.4. Market size and forecast, by application

7.4.5. Market size and forecast, by country

7.4.5.1. Japan market size and forecast, by test type

7.4.5.2. Japan market size and forecast, by technology

7.4.5.3. Japan market size and forecast, by application

7.4.5.4. China market size and forecast, by test type

7.4.5.5. China market size and forecast, by technology

7.4.5.6. China market size and forecast, by application

7.4.5.7. Australia market size and forecast, by test type

7.4.5.8. Australia market size and forecast, by technology

7.4.5.9. Australia market size and forecast, by application

7.4.5.10. India market size and forecast, by test type

7.4.5.11. India market size and forecast, by technology

7.4.5.12. India market size and forecast, by application

7.4.5.13. South Korea market size and forecast, by test type

7.4.5.14. South Korea market size and forecast, by technology

7.4.5.15. South Korea market size and forecast, by application

7.4.5.16. Rest of Asia-Pacific market size and forecast, by test type

7.4.5.17. Rest of Asia-Pacific market size and forecast, by technology

7.4.5.18. Rest of Asia-Pacific market size and forecast, by application

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. Market size and forecast, by test type

7.5.3. Market size and forecast, by technology

7.5.4. Market size and forecast, by application

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil market size and forecast, by test type

7.5.5.2. Brazil market size and forecast, by technology

7.5.5.3. Brazil market size and forecast, by application

7.5.5.4. Saudi Arabia market size and forecast, by test type

7.5.5.5. Saudi Arabia market size and forecast, by technology

7.5.5.6. Saudi Arabia market size and forecast, by application

7.5.5.7. South Africa market size and forecast, by test type

7.5.5.8. South Africa market size and forecast, by technology

7.5.5.9. South Africa market size and forecast, by application

7.5.5.10. Rest of LAMEA market size and forecast, by test type

7.5.5.11. Rest of LAMEA market size and forecast, by technology

7.5.5.12. Rest of LAMEA market size and forecast, by application

Chapter: 8: COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product portfolio

8.1.5. Business performance

8.2. BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.)

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product portfolio

8.2.5. Business performance

8.2.6. Key strategic moves and developments

8.3. DANAHER CORPORATION (CEPHEID)

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.3.6. Key strategic moves and developments

8.4. EUROFINS SCIENTIFIC

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Product portfolio

8.4.4. Business performance

8.4.5. Key strategic moves and developments

8.5. F. HOFFMANN-LA ROCHE LTD.

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. ILLUMINA, INC.

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

8.7. MYRIAD GENETICS, INC. (MYRIAD RBM, INC.)

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.8. NOVARTIS INTERNATIONAL AG

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Business performance

8.9. QIAGEN N.V. (FORMULATRIX, INC.)

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Product portfolio

8.9.4. Business performance

8.9.5. Key strategic moves and developments

8.10. THERMO FISHER SCIENTIFIC, INC.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance

TABLE 01. GLOBAL GENETIC TESTING MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 02. GLOBAL GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 03. GLOBAL GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 04. GLOBAL GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 05. GLOBAL GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING BY REGION, 2017–2025 ($MILLION)

TABLE 06. GLOBAL GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 07. GLOBAL GENETIC TESTING MARKET FOR OTHER TYPES, BY REGION, 2017–2025 ($MILLION)

TABLE 08. GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 09. GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 10. GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 11. GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY TYPE, 2017–2025 ($MILLION)

TABLE 12. GENETIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2017–2025 ($MILLION)

TABLE 13. GENETIC TESTING MARKET FOR OTHER MOLECULAR TESTS, BY REGION, 2017–2025 ($MILLION)

TABLE 14. GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2017–2025 ($MILLION)

TABLE 15. GLOBAL GENETIC TESTING MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 16. GLOBAL GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)

TABLE 17. GLOBAL GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)

TABLE 18. GLOBAL GENETIC TESTING MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)

TABLE 19. GLOBAL GENETIC TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2025 ($MILLION)

TABLE 20. GENETIC TESTING MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 21. NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 22. NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 23. NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 24. NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 25. U.S. GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 26. U.S. GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 27. U.S. GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 28. CANADA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 29. CANADA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 30. CANADA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 31. MEXICO GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 32. MEXICO GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 33. MEXICO GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 34. EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 35. EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 36. EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 37. EUROPE GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 38. GERMANY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 39. GERMANY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 40. GERMANY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 41. FRANCE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 42. FRANCE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 43. FRANCE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 44. UK GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 45. UK GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 46. UK GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 47. ITALY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 48. ITALY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 49. ITALY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 50. SPAIN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 51. SPAIN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 52. SPAIN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 53. REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 54. REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 55. REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 56. ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 57. ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 58. ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 59. ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 60. JAPAN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 61. JAPAN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 62. JAPAN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 63. CHINA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 64. CHINA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 65. CHINA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 66. AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 67. AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 68. AUSTRALIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 69. INDIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 70. INDIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 71. INDIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 72. SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 73. SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 74. SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 75. REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 76. REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 77. REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 78. LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 79. LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 80. LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 81. LAMEA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 82. BRAZIL GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 83. BRAZIL GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 84. BRAZIL GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 85. SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 86. SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 87. SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 88. SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 89. SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 90. SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 91. REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2017–2025 ($MILLION)

TABLE 92. REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 93. REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 94. ABBOTT: COMPANY SNAPSHOT

TABLE 95. ABBOTT: OPERATING SEGMENTS

TABLE 96. ABBOTT: PRODUCT PORTFOLIO

TABLE 97. BIO-RAD: COMPANY SNAPSHOT

TABLE 98. BIO-RAD: OPERATING SEGMENTS

TABLE 99. BIO-RAD: PRODUCT PORTFOLIO

TABLE 100. DANAHER: COMPANY SNAPSHOT

TABLE 101. DANAHER: OPERATING SEGMENTS

TABLE 102. DANAHER: PRODUCT PORTFOLIO

TABLE 103. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT

TABLE 104. EUROFINS SCIENTIFIC.: PRODUCT PORTFOLIO

TABLE 105. ROCHE: COMPANY SNAPSHOT

TABLE 106. ROCHE: OPERATING SEGMENTS

TABLE 107. ROCHE: PRODUCT PORTFOLIO

TABLE 108. ILLUMINA: COMPANY SNAPSHOT

TABLE 109. ILLUMINA: OPERATING SEGMENTS

TABLE 110. ILLUMINA: PRODUCT PORTFOLIO

TABLE 111. MYRIAD: COMPANY SNAPSHOT

TABLE 112. MYRIAD: OPERATING SEGMENTS

TABLE 113. MYRIAD: PRODUCT PORTFOLIO

TABLE 114. NOVARTIS AG: COMPANY SNAPSHOT

TABLE 115. NOVARTIS: OPERATING SEGMENTS

TABLE 116. NOVARTIS AG: PRODUCT PORTFOLIO

TABLE 117. QIAGEN: COMPANY SNAPSHOT

TABLE 118. QIAGEN: PRODUCT PORTFOLIO

TABLE 119. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 120. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 121. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO